Expertise in
26
conditions

Dr. Camilo E. Fadul

Oncology
UVA Health Neuro Oncology
1240 Lee St Fl 3, 
Charlottesville, VA 
Accepting New Patients
Offers Telehealth
Expertise in
26
conditions
UVA Health Neuro Oncology
1240 Lee St Fl 3, 
Charlottesville, VA 

Overview

Camilo Fadul is an Oncologist practicing medicine in Charlottesville, Virginia.

Dr. Fadul is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Oligodendroglioma, Glioma, Brain Tumor, and Astrocytoma.

He is actively involved in clinical research, co-authoring 75 peer reviewed articles and participating in 6 clinical trials. Dr. Fadul is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in NH

Hospital Affiliations

University Of Virginia Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

UVA Health Neuro Oncology
1240 Lee St Fl 3, Charlottesville, VA 22908

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas
Evaluating the Expression Levels of microRNA-10b in Patients With Gliomas
Enrollment Status: Terminated
Publish Date: September 15, 2025
A Phase I Study Targeting Newly Diagnosed Glioblastoma With Anti-CD3 × Anti-EGFR Bispecific Antibody Armed T Cells (EGFR BATs) in Combination With Radiation and Temozolomide
A Phase I Study Targeting Newly Diagnosed Glioblastoma With Anti-CD3 × Anti-EGFR Bispecific Antibody Armed T Cells (EGFR BATs) in Combination With Radiation and Temozolomide
Enrollment Status: Completed
Publish Date: March 06, 2025
Intervention Type: Drug
Study Drug: EGFR BATs+TMZ
Study Phase: Phase 1
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Phase I Study of Anti-CD3 x Anti-Her2/Neu (Her2Bi) Armed Activated T Cells (ATC) in Patients With Breast Cancer Leptomeningeal Metastases
A Phase I Study of Anti-CD3 x Anti-Her2/Neu (Her2Bi) Armed Activated T Cells (ATC) in Patients With Breast Cancer Leptomeningeal Metastases
Enrollment Status: Terminated
Publish Date: December 20, 2022
Intervention Type: Drug
Study Drug: HER2 BATs
Study Phase: Phase 1
Early-Phase Study to Assess Tumor Pharmacokinetics and Efficacy of the CDK4/6 Inhibitor Ribociclib (LEE011) in Patients With Recurrent Glioblastoma or Anaplastic Glioma
Early-Phase Study to Assess Tumor Pharmacokinetics and Efficacy of the CDK4/6 Inhibitor Ribociclib (LEE011) in Patients With Recurrent Glioblastoma or Anaplastic Glioma
Enrollment Status: Unknown
Publish Date: June 07, 2018
Intervention Type: Drug
Study Drug: Ribociclib
Study Phase: Phase 1
View 5 Less Clinical Trials

75 Total Publications

Long-term survival with stereotactic radiosurgery and 100+ cycles of Keytruda in a patient with brain metastases from melanoma.
Long-term survival with stereotactic radiosurgery and 100+ cycles of Keytruda in a patient with brain metastases from melanoma.
Journal: Journal of neuro-oncology
Published: April 16, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Benjamin W. Purow
Hematology | Oncology
Expertise in
21
conditions
Dr. Benjamin W. Purow
Hematology | Oncology
Referral may be required

UVA Health Neuro Oncology

1240 Lee St Fl 3, 
Charlottesville, VA 
 (0.1 miles away)
434-924-9333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Benjamin Purow is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Purow is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Purow is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

UVA Health Emily Couric Clinical Cancer Center

1240 Lee St, 
Charlottesville, VA 
 (1.2 miles away)
434-924-9333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ryan Gentzler is an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Gentzler is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Gentzler is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

UVA Health University Medical Center

1215 Lee St, 
Charlottesville, VA 
 (1.2 miles away)
434-924-3627
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Dreicer is an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Dreicer is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Orchiectomy, and Prostatectomy. Dr. Dreicer is currently accepting new patients.

Frequently Asked Questions about Dr. Camilo E. Fadul

How do I make an appointment with Dr. Camilo E. Fadul?

You can book an appointment with Dr. Camilo E. Fadul by calling their office at 434-924-9333. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Camilo E. Fadul a top-rated expert for Oligodendroglioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Camilo E. Fadul is classified as an Elite expert for Oligodendroglioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Camilo E. Fadul specialize in?

While Dr. Camilo E. Fadul is a Oncology, they have specific expertise in Oligodendroglioma, Glioma, and Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Camilo E. Fadul participate in research or clinical trials?

Yes. Dr. Camilo E. Fadul has published 75 articles and abstracts on conditions like Oligodendroglioma. You can view a list of Dr. Camilo E. Fadul's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Camilo E. Fadul accept my insurance?

Dr. Camilo E. Fadul accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 434-924-9333 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fadul's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 8 Advanced Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile